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Abstract. Particularities of gastroduodenal pathology in children, associated with cytotoxic CAGA-positive 
strains of Helicobacter pylori. Gerasimenko O.N. The aim of the study was to investigate the characteristics of 
inflammatory gastroduodenal diseases in children, associated with CagA-positive strains of H. pylori. We observed 283 
children aged 7 to 17 years with chronic gastroduodenal pathology in exacerbation stage; endoscopic examination of 
the esophagus, stomach and duodenum was performed, total Ig M, A, G to Ag SagA H. pylori protein in blood serum by 
ELISA was determined. The study group included 156 patients infected with cytotoxic CagA (+) strains of H. pylori (H. 
pylori-positive status), comparison group - 59 (20,9%) patients with H. pylori-negative status. It was shown that 55.1% 
of patients observed were infected with cytotoxic CagA (+) strains of H. pylori. The intensity of clinical symptoms and 
the severity of inflammatory changes in stomach and duodenum mucosa in children with H. pylori infection is 
associated with cytotoxic strains of CAG A H. pylori. Presence of extensive gastritis (34,6%; p<0,05), lymphoid 
hyperplasia (16,0%; p <0,05), turbid mucus in the gastric lumen are the special features of endoscopic changes in 
children with H. pylori-positive status. 
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M ± m 
. pylori 
 % n=59 
M ± m 
2
p
 13,49±0,54 13,42±0,53 
 93(59,61%) 33 (55,93%)   
 63 (40,39%) 26 (44,06%)   
 20,54±0,70* 18,41±0,56  Pu<0,05 
 ( .) 28,63±4,17 27,55±5,86   
 2,5±0,26* 2,0±0,13  Pu<0,05 
 39 (25%) 12 (20,34%)   
 28 (18%) 12 (20,34%)   
 25 (16%) 18(30,51%)* 2  =4,74 P= 0,0294 
 64 (41%) 17 (28,81%)   
:  P – , 2(Chi-squre test); Pu - ,  U-
 – i; * -  p < 0,05. 
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M ± m 
2
p
 93 (59,6%)** 5 (8,5%) 2=43,099 P< 0,0001 
 36 (23,1%)** 36 (61,0%) 2=25,99 P< 0,0001 
 27 (17,3 %)* 18 (30,5%) 2 =3,75 P= 0,05 
- 85( 54,5%) 38 (64,4%) 2 =1,34 P=0,25 
 25 (16,0%)* 2 (3,4%) 2 =5,13 P = 0,024 
- 10 (6,4%) 3 (5,1%) 2 =0,0019 P= 0,97 
« »  « » 26 (16,7%) 7 (11,9%) 2 =0,44 P = 0,51 
 54 (34,6%)* 10 (16,9%) 2 =5,57 P = 0,018 
:  P – , 2.(Chi-squre test); * -  p < 0,05; ** -  p < 0,01. 
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